A young Chinese prodigy determined to help his grandmother with Alzheimer’s invented an AI mini-computer to help her recognize family members and find the way home.
Nanodevices are the newest weapon in medicine’s growing arsenal to fight Alzheimer’s. They capture dangerous peptides before they can assemble to form Alzheimer’s plaques in the brain.
Research shows that lecanemab is the first drug ever to slow cognitive decline in Alzheimer’s. Learn more.
A certain protein in the blood can be used to predict the eventual appearance of Alzheimer’s. Will this allow for early intervention?
Eli Lilly Company’s TRAILBLAZER-ALZ 2 Phase 3 study shows that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease. Learn more.
A new form of Omega-3 has successfully increased DHA in the retina and reduced eye problems associated with Alzheimer’s-like processes.
The AlzoSure® Blood Test can catch Alzheimer’s two years before symptoms appear. Its development could not be more timely. With FDA approval of lecanemab for Alzheimer’s, this accurate and economical screening tool will dramatically assist patients most likely to benefit from early treatment.
BREAKTHROUGH: Researchers have developed a blood test that can predict the risk of future cognitive decline and Alzheimer’s. The test checks levels of a fragment
DIAGNOSIS: A highly sensitive blood test has reached the market that can identify whether it is likely a patient has amyloid plaques in the brain,
PROGRESS: ApoE4 is the best known “Alzheimer’s Gene”. Gladstone Institute scientists successfully changed the gene’s structure. This eliminated certain signs of Alzheimer’s, restored normal cell
Higher midlife omega-3 levels were linked to lower early-onset dementia risk. It’s not proof — but it’s a meaningful signal worth paying attention to.
In a one-hour seminar, a leading neurologist answers the most important questions families ask about what these new therapies can realistically deliver — from effectiveness and safety to eligibility, infusion logistics, cost, and access.
Here’s a good activity caregivers can use easily, contributed by one of our readers. It’s a simple game, great in mid-stage Alzheimer’s.
A new test that can be completed in less than three minutes enables simple, accurate detection of cognitive impairment and Alzheimer’s in cognitively normal adults, including those with no symptoms of dementia. Find out more.
Scientists say the neurons responsible for transforming experiences into memories are always the first to go in Alzheimer’s. Now they’re taking a closer look to try to figure out why, and what to do about it.
A research study finds when young healthy men had a full, uninterrupted night of rest, their blood levels showed a reduced level of tau, the biomarker for Alzheimer’s disease. The level was higher when they lost just one night of sleep. Learn more.
Here’s a good activity caregivers can use easily, contributed by one of our readers. It’s a simple game, great in mid-stage Alzheimer’s.
No spam, only news and updates.
